NCT06268977CompletedPhase 4
Adding SGLt2 Inhibitors to Patients With Type 2 Diabetes
Efficacy and Safety of Incorporating Sodium-glucose Cotransporter-2 Inhibitors to Regimens of Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
To detect the efficacy of SGLT2i in improving the metabolic parameters in patients with type 2 diabetes. \- To detect the side-effects of SGLT2i
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 482 (actual)
- First submitted
- 17 Jan 2024
- Start date
- 1 Apr 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Assiut University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06268977
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 482
- From 1 Apr 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients already receiving SGLT2i as part of their treatment
Other illness
- history of severe hypoglycemia
- patients with history of weight loss
- Patients with history of recurrent UTI
Lab values
- very high blood glucose (A1c more than 11%) or presenting at the clinic with BG above 300 mg/dL.
Other
- clinical evidence of dehydration.
- Frailty.
Who the study is looking for
- Adults (≥18 years)
- both genders ( male and female)
- type 2 diabetic patients
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assiut University hospital Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.